1. Home
  2. SYRE vs RLJ Comparison

SYRE vs RLJ Comparison

Compare SYRE & RLJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • RLJ
  • Stock Information
  • Founded
  • SYRE 2013
  • RLJ 2011
  • Country
  • SYRE United States
  • RLJ United States
  • Employees
  • SYRE N/A
  • RLJ N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • RLJ Real Estate Investment Trusts
  • Sector
  • SYRE Health Care
  • RLJ Real Estate
  • Exchange
  • SYRE Nasdaq
  • RLJ Nasdaq
  • Market Cap
  • SYRE 1.1B
  • RLJ 1.2B
  • IPO Year
  • SYRE 2016
  • RLJ 2011
  • Fundamental
  • Price
  • SYRE $16.26
  • RLJ $7.22
  • Analyst Decision
  • SYRE Buy
  • RLJ Hold
  • Analyst Count
  • SYRE 5
  • RLJ 7
  • Target Price
  • SYRE $55.00
  • RLJ $9.46
  • AVG Volume (30 Days)
  • SYRE 545.5K
  • RLJ 1.4M
  • Earning Date
  • SYRE 08-06-2025
  • RLJ 08-07-2025
  • Dividend Yield
  • SYRE N/A
  • RLJ 8.11%
  • EPS Growth
  • SYRE N/A
  • RLJ N/A
  • EPS
  • SYRE N/A
  • RLJ 0.26
  • Revenue
  • SYRE N/A
  • RLJ $1,373,555,000.00
  • Revenue This Year
  • SYRE N/A
  • RLJ $0.81
  • Revenue Next Year
  • SYRE N/A
  • RLJ $1.59
  • P/E Ratio
  • SYRE N/A
  • RLJ $28.42
  • Revenue Growth
  • SYRE N/A
  • RLJ 2.82
  • 52 Week Low
  • SYRE $10.91
  • RLJ $6.16
  • 52 Week High
  • SYRE $40.26
  • RLJ $10.84
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 48.34
  • RLJ 38.54
  • Support Level
  • SYRE $16.43
  • RLJ $7.65
  • Resistance Level
  • SYRE $17.70
  • RLJ $7.92
  • Average True Range (ATR)
  • SYRE 0.99
  • RLJ 0.20
  • MACD
  • SYRE -0.02
  • RLJ -0.06
  • Stochastic Oscillator
  • SYRE 37.17
  • RLJ 7.93

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.

Share on Social Networks: